Insights

CE Milestone Vascular Graft Solutions has achieved CE Mark approval for FRAME FR, highlighting regulatory credibility and potential access to European markets for vascular repair and stabilization products.

Clinical Validation Strong preclinical and clinical data on VEST showing reduced vein graft disease and improved hemodynamics positions the company to target surgeons and vascular clinics seeking evidence-based graft longevity improvements.

Growth Readiness Current revenue range and mid-sized team indicate a lean, deployable commercial force with possible upside through partnerships, distribution agreements, or OEM collaborations to expand market reach.

Channel Expand Existing tech stack and digital presence (WordPress, Shopify, Cloud services) enable scalable e-commerce, lead capture, and global outreach; potential for digital marketing programs to accelerate adoption in EU and other regions.

Strategic Fit Product focus on external mechanical support for vein grafts aligns with adjacent opportunities in dialysis access and vascular grafting markets, suggesting cross-sell or co-development with large device players or distributors in the sector.

Similar companies to Vascular Graft Solutions

Vascular Graft Solutions Tech Stack

Vascular Graft Solutions uses 8 technology products and services including gstatic.com, Cloudflare, WordPress, and more. Explore Vascular Graft Solutions's tech stack below.

Vascular Graft Solutions's Email Address Formats

Vascular Graft Solutions uses at least 3 email formats:
Vascular Graft Solutions Email FormatsExamplePercentage
First@graftsolutions.comJohn@graftsolutions.com
86%
First.Last@graftsolutions.comJohn.Doe@graftsolutions.com
9%
First.L@graftsolutions.comJohn.D@graftsolutions.com
5%

Frequently Asked Questions

What is Vascular Graft Solutions's official website and social media links?

Minus sign iconPlus sign icon
Vascular Graft Solutions's official website is graftsolutions.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Vascular Graft Solutions generate?

Minus sign iconPlus sign icon
As of September 2026, Vascular Graft Solutions's annual revenue is estimated to be $1M - $10M.

What is Vascular Graft Solutions's NAICS code?

Minus sign iconPlus sign icon
Vascular Graft Solutions's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Vascular Graft Solutions have currently?

Minus sign iconPlus sign icon
As of September 2026, Vascular Graft Solutions has approximately 17 employees across 1 continents, including Asia. Key team members include Vp Legal: D. E., Vp Operations And Manufacturing, Project Manager: L. Y. and Vp Clinical And Regulatory Affairs: O. Y. Explore Vascular Graft Solutions's employee directory with LeadIQ.

What industry does Vascular Graft Solutions belong to?

Minus sign iconPlus sign icon
Vascular Graft Solutions operates in the Medical Equipment Manufacturing industry.

What technology does Vascular Graft Solutions use?

Minus sign iconPlus sign icon
Vascular Graft Solutions's tech stack includes gstatic.com, Cloudflare, WordPress, Shopify, Microsoft 365, Google Cloud, OWL Carousel and WP Engine.

What is Vascular Graft Solutions's email format?

Minus sign iconPlus sign icon
Vascular Graft Solutions's email format typically follows the pattern of First@graftsolutions.com. Find more Vascular Graft Solutions email formats with LeadIQ.

How much funding has Vascular Graft Solutions raised to date?

Minus sign iconPlus sign icon
As of September 2026, Vascular Graft Solutions has raised $4.8M in funding. The last funding round occurred on Jun 03, 2018.

When was Vascular Graft Solutions founded?

Minus sign iconPlus sign icon
Vascular Graft Solutions was founded in 2009.
Vascular Graft Solutions logo

Vascular Graft Solutions

Medical Equipment ManufacturingTel Aviv, Israel11-50 Employees

Vascular Graft Solutions is a medical equipment manufacturer established in 2009 and based in Tel Aviv, Israel. The company focuses on developing and bringing to market solutions aimed at improving outcomes in bypass surgeries, with its main product being the VEST system, an external support mechanism designed to enhance the longevity of autologous vein grafts by stabilizing wall tension and improving lumen uniformity. Through pre-clinical and clinical studies, the technology has shown potential to optimize vein graft hemodynamics and mitigate vein graft disease, with randomized trials and real-world data from Europe supporting its biomechanical effects and associated improvements in clinical outcomes. The target customers are likely medical professionals and institutions involved in vascular and dialysis-related procedures, seeking devices that address complications of vein grafts and high-flow arteriovenous fistulas, as evidenced by regulatory milestones such as CE Mark approval for another device in the recent news. The company operates in the medical device manufacturing sector, positioning itself as a specialized provider of innovative solutions for vascular and hemodialysis-related vascular access needs.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $4.8M

    Vascular Graft Solutions has raised a total of $4.8M of funding over 5 rounds. Their latest funding round was raised on Jun 03, 2018 as a Series B.

  • $1M - $10M

    Vascular Graft Solutions's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.